Recent Quotes
My Watchlist
Indicators
Silicon Valley 150
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

PMGC Holdings Inc. - Common Stock (NQ:ELAB)

3.600 +0.220 (+6.51%)
Streaming Delayed Price Updated: 3:23 PM EST, Jan 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about PMGC Holdings Inc. - Common Stock

< Previous 1 2 3 4 Next >
News headline image
PMGC Holdings Inc. Announces Strategic Share Acquisition in Micro Modular Reactor (MMR) Focused Nuclear Energy Company, Nuclea Energy Inc.
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
PMGC Holdings Inc. Announces Reverse Stock Split Effective January 6, 2026
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
PMGC Holdings Inc. Announces Anticipated Reverse Stock Split
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
AGA Precision Systems LLC Achieves Globally Recognized AS9100 Certification for Aerospace, Defense, and Space Manufacturing, Exploring Future Humanoid Robotics Integration
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
NorthStrive Biosciences Advances to Phase III of AI-Driven Drug Discovery Program Toward Validation of Multiple Potential Drug Compounds & Discoveries
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
PMGC Holdings Inc. [Nasdaq: ELAB] Congratulates General Enterprise Ventures, Inc. [NYSE: CITR] on Its Uplisting to the NYSE American, Highlights Equity Stake
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
PMGC Holdings Inc. Announces AGA Precision Systems LLC’s ITAR (International Traffic in Arms Regulations) Registration Approval
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
PMGC Holdings Inc.’s Subsidiary, AGA Precision Systems LLC, Completes Acquisition of Indarg Engineering, Inc. Expanding Aerospace and Defense Manufacturing Platform
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
PMGC Holdings Inc. Announces Over $711,000.00 in Sales Backlog at AGA Precision Systems LLC and Provides Corporate Update
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
Northstrive Biosciences Announces Completion of Phase II of AI Development Program with YuvaBio Using MitoNova™ Artificial Intelligence (AI) Platform to Develop Therapies for Obesity and Cardiometabolic Diseases
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
PMGC Holdings Inc. Announces Anticipated Reverse Stock Split
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
PMGC Holdings Inc. Announces $1.67 Million in Gross Proceeds from Warrant Inducement with Institutional Investors Priced At-The Market Under Nasdaq Rules
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
PMGC Holdings Inc. Announces Filing of Quarterly Report on Form 10-Q
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
PMGC Holdings Inc. Terminates LOI to Focus on Acquiring High-Growth CNC Precision Manufacturing Companies Serving Aerospace, Defense, and Industrial Markets
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
PMGC Holdings Inc. Completes Acquisition of CNC Machining Company - AGA Precision Systems LLC
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
Pacific Sun Packaging, a Subsidiary of PMGC Holdings, Announces Attendance at 2025 ITAD Summit to Showcase Custom Protective Packaging for Enterprise IT Hardware
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
PMGC Holdings Inc. Completes Acquisition of Custom IT Packaging Company Pacific Sun Packaging with Over $2,000,000 in Combined Revenue for Fiscal Years 2023 and 2024
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
PMGC Holdings Inc. Signs Non-Binding LOI to Acquire CNC Aerospace Manufacturer Generating $4.5 Million in Annual Revenue
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) to Accept Term Sheet from Leading Wall Street Bank Behind Many Leading Crypto Strategies
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
Northstrive Biosciences Announces Initiation of Phase II of Collaboration to Develop AI Powered Therapies for Obesity and Cardiometabolic Diseases
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based AS9100D & ISO 9001:2015 Certified CNC Machine Shop Serving Aerospace, Defense, and Industrial Markets for over 35 years
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based Electronics Manufacturing Company
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
NorthStrive Biosciences Announces Completion of Phase I Strategic Review for EL-22 Targeting Muscle Loss Associated with GLP-1 Weight Loss Drugs and Age-Related Sarcopenia
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
PMGC Holdings Inc. Announces Filing of Quarterly Report on Form 10-Q
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
PMGC Capital LLC, a Subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), To File Schedule 13D Reporting 5.09% Stake in Alaunos Therapeutics, Inc. (Nasdaq: TCRT)
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
Northstrive Biosciences Signs Binding Term Sheet with Modulant Biosciences for Exclusive Global Animal Health Licensing of EL-22
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
RESEND - Northstrive Biosciences Strengthens IP Portfolio with New US Patent Filings for EL-22 and EL-32 Programs Covering Obesity and Animal Health
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
Northstrive Biosciences Strengthens IP Portfolio with New US Patent Filings for EL-22 and EL-32 Programs Covering Obesity and Animal Health
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
Northstrive Biosciences Co-Founder Featured on Bear Bull Traders Following Announcement of Positive FDA Response Supporting Submission of IND for EL-22 Phase 2 Clinical Trial
From PMGC Holdings Inc.
Via GlobeNewswire
News headline image
Northstrive Biosciences Announces Positive FDA Response Supporting A Submission of IND for a Phase 2 Clinical Trial for EL-22 in Combination with GLP-1 Receptor Agonist for Obesity Treatment
From PMGC Holdings Inc.
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.